ITCI
Intra-Cellular Therapies Inc
Price:  
83.88 
USD
Volume:  
434,441.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ITCI EV/EBITDA

-114.7%
Upside

As of 2024-12-13, the EV/EBITDA ratio of Intra-Cellular Therapies Inc (ITCI) is -69.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ITCI's latest enterprise value is 8,428.65 mil USD. ITCI's TTM EBITDA according to its financial statements is -121.08 mil USD. Dividing these 2 quantities gives us the above ITCI EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.7x - 10.9x 10.0x
Forward P/E multiples 16.7x - 20.3x 19.2x
Fair Price (14.72) - (8.07) (12.29)
Upside -117.5% - -109.6% -114.7%
83.88 USD
Stock Price
(12.29) USD
Fair Price

ITCI EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-11 -69.61
2024-12-10 -68.94
2024-12-09 -70.56
2024-12-06 -70.20
2024-12-05 -69.79
2024-12-04 -71.42
2024-12-03 -70.86
2024-12-02 -71.49
2024-11-29 -71.16
2024-11-27 -71.98
2024-11-26 -71.84
2024-11-25 -70.58
2024-11-22 -71.19
2024-11-21 -70.98
2024-11-20 -71.15
2024-11-19 -69.15
2024-11-18 -68.38
2024-11-15 -69.21
2024-11-14 -72.89
2024-11-13 -73.41
2024-11-12 -73.65
2024-11-11 -76.34
2024-11-08 -76.10
2024-11-07 -75.42
2024-11-06 -74.48
2024-11-05 -74.30
2024-11-04 -71.62
2024-11-01 -71.94
2024-10-31 -70.37
2024-10-30 -71.00
2024-10-29 -63.37
2024-10-28 -63.43
2024-10-25 -62.54
2024-10-24 -62.40
2024-10-23 -61.85
2024-10-22 -63.66
2024-10-21 -63.51
2024-10-18 -64.76
2024-10-17 -65.06
2024-10-16 -62.79
2024-10-15 -61.58
2024-10-14 -60.82
2024-10-11 -62.50
2024-10-10 -60.62
2024-10-09 -60.29
2024-10-08 -59.55
2024-10-07 -58.50
2024-10-04 -59.99
2024-10-03 -59.43
2024-10-02 -59.75